STOCK TITAN

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc. (NTRA), reported sales of common stock under a pre-established trading plan. On 09/12/2025 the filing shows a total of 5,000 shares sold (4,500 and 500 shares) at prices reported as a weighted average of $170.3083 for one block and $172.64 for the other, with the larger block sold at prices ranging from $170.00 to $170.93. The Form states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

The filing lists 2,360,852 shares beneficially owned directly following the reported transactions. It also records indirect holdings attributed to a spouse of 25,500 and 25,000 shares on separate lines. The Form 4 was signed by an attorney-in-fact on 09/16/2025.

Matthew Rabinowitz, Presidente Esecutivo e Direttore di Natera, Inc. (NTRA), ha riportato vendite di azioni ordinarie nell'ambito di un piano di negoziazione prestabilito. Il 12/09/2025 la dichiarazione mostra un totale di 5.000 azioni vendute (4.500 e 500 azioni) a prezzi riportati come media ponderata di $170,3083 per un blocco e $172,64 per l'altro, con il blocco maggiore venduto a prezzi compresi tra $170,00 e $170,93. Il modulo afferma che le vendite sono state eseguite ai sensi di un piano di negoziazione Rule 10b5-1 adottato dalla persona che riporta il dato il 13 giugno 2025.

La dichiarazione elenca 2.360.852 azioni detenute direttamente dopo le operazioni riportate. Riporta anche partecipazioni indirecte attribuite a un coniuge di 25.500 e 25.000 azioni su righe separate. Il Form 4 è stato firmato da un procuratore il 16/09/2025.

Matthew Rabinowitz, Presidente Ejecutivo y Director de Natera, Inc. (NTRA), informó ventas de acciones comunes bajo un plan de negociación predeterminado. El 12/09/2025 la presentación muestra un total de 5.000 acciones vendidas (4.500 y 500) a precios reportados como promedio ponderado de $170.3083 para un bloque y $172.64 para el otro, siendo el bloque mayor vendido a precios que oscilan entre $170.00 y $170.93. El Formulario indica que las ventas se realizaron conforme a un plan de negociación 10b5-1 adoptado por la persona que reporta el dato el 13 de junio de 2025.

La declaración lista 2.360.852 acciones poseídas de forma beneficiosa directamente después de las transacciones reportadas. También registra participaciones indirectas atribuidas a un cónyuge de 25.500 y 25.000 acciones en líneas separadas. El Formulario 4 fue firmado por un apoderado el 16/09/2025.

Matthew Rabinowitz, Natera, Inc.의 실행 위원회 의장 겸 이사로서 사전에 확립된 거래 계획에 따라 보통주 매도를 보고했습니다. 2025년 9월 12일 공시에는 총 5,000주 매도가 표시되며(4,500주 및 500주), 한 블록은 $170.3083, 다른 블록은 $172.64의 가중평균가로 보고되었고, 더 큰 블록은 $170.00에서 $170.93 사이의 가격으로 매도되었습니다. 양식은 매매가 보고 의무자이 입수한 2025년 6월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 진행되었음을 명시합니다.

공시는 거래 보고 직후 직접 보유한 2,360,852주의 주식을 나열합니다. 또한 배우자에게 귀속된 간접 보유로 25,500주25,000주가 별도 행에 기록됩니다. Form 4는 2025년 9월 16일에 대리인이 서명했습니다.

Matthew Rabinowitz, Président Exécutif et Directeur de Natera, Inc. (NTRA), a renseigné des ventes d'actions ordinaires dans le cadre d'un plan de négociation préétabli. Le 12/09/2025, le dépôt montre un total de 5 000 actions vendues (4 500 et 500 actions) à des prix rapportés comme moyenne pondérée de 170,3083 USD pour un bloc et 172,64 USD pour l'autre, le bloc le plus important ayant été vendu à des prix allant de 170,00 à 170,93 USD. Le formulaire indique que les ventes ont été effectuées conformément à un plan de négociation Rule 10b5-1 adopté par la personne qui déclare le fait le 13 juin 2025.

Le dépôt répertorie 2 360 852 actions détenues directement après les transactions déclarées. Il indique aussi des participations indirectes attribuées à un conjoint de 25 500 et 25 000 actions sur des lignes séparées. Le formulaire 4 a été signé par un mandataire le 16/09/2025.

Matthew Rabinowitz, Vorstandsvorsitzender und Direktor von Natera, Inc. (NTRA), meldete Verkäufe von Stammaktien im Rahmen eines vorab festgelegten Handelplans. Am 12.09.2025 zeigt die Einreichung insgesamt 5.000 Aktien verkauft (4.500 und 500 Aktien) zu als gewichteter Durchschnitt berichteten Preisen von $170,3083 für einen Block und $172,64 für den anderen, wobei der größere Block zu Preisen von $170,00 bis $170,93 verkauft wurde. Das Formular besagt, dass die Verkäufe gemäß einem am 13. Juni 2025 von der berichtenden Person angenommenen Rule 10b5-1-Handelsplan durchgeführt wurden.

Die Einreichung listet 2.360.852 Aktien unmittelbar nach den berichteten Transaktionen direkt gehalten. Es vermerkt außerdem indirekte Beteiligungen, die einem Ehepartner von 25.500 und 25.000 Aktien zugeordnet sind, auf separaten Zeilen. Das Formular 4 wurde von einem Rechtsvertreter am 16.09.2025 unterzeichnet.

Matthew Rabinowitz ، رئيس مجلس الإدارة التنفيذي والمدير في Natera, Inc. (NTRA)، أبلغ عن بيع أسهم عادية وفق خطة تداول محددة سلفاً. في 12/09/2025 يظهر الملف إجمالاً 5,000 سهم مباعة (4,500 و500 سهم) بأسعار مُبلغ عنها كمتوسط مُوزون لـ $170.3083 لسلة و$172.64 للأخرى، مع أن السلس الأكبر بيع عند أسعار تتراوح بين $170.00 و $170.93. ينص النموذج أن المبيعات تمت وفقاً لخطة تداول Rule 10b5-1 اعتمدها الشخص المبلغ في 13 يونيو 2025.

تسرد الإقرارية 2,360,852 سهم مملوكة مباشرة بعد المعاملات المبلغ عنها. كما يسجل أيضاً حصصاً غير مباشرة تُنسب إلى زوج/زوجة بمقدار 25,500 و 25,000 سهم على أسطر منفصلة. تم توقيع النموذج 4 بواسطة وكيل/وكيلة في 16/09/2025.

Matthew Rabinowitz,Natera, Inc.(NTRA)的执行董事长兼董事报告了按既定交易计划进行的普通股出售。在2025/09/12的申报中,总计5,000股已售(4,500股和500股),按两笔的加权平均价报告,第一笔为$170.3083,第二笔为$172.64,其中较大型块的成交价在$170.00到$170.93之间。表格指出销售是依据报告人于2025年6月13日采纳的10b5-1规则的交易计划执行的。

申报交易后,直接持有的2,360,852股有益所有权被列出。还记录了归属于配偶的间接持股,分别为25,50025,000股,分行列出。Form 4于2025/09/16由代理人签署。

Positive
  • Sales executed under a Rule 10b5-1 plan, indicating pre-arranged trades rather than opportunistic insider timing
  • Timely disclosure of transactions and remaining direct ownership (2,360,852 shares) in a filed Form 4
Negative
  • None.

Insights

TL;DR: Routine insider sales under a 10b5-1 plan; disclosure aligns with standard governance practice.

The transactions disclosed are sales executed under a Rule 10b5-1 plan adopted on June 13, 2025, which indicates pre-arranged, time-based dispositions rather than opportunistic trading tied to contemporaneous material nonpublic information. The filing provides the number of shares sold (4,500 and 500), weighted average prices for the larger block and the explicit price for the smaller block, and the direct beneficial ownership remaining at 2,360,852 shares. From a governance perspective, use of a 10b5-1 plan and timely Form 4 reporting are consistent with compliance and insider trading controls.

TL;DR: Insiders sold 5,000 shares total; transaction size is small relative to reported direct holdings.

The combined sale of 5,000 shares on 09/12/2025 at average prices around $170–$173 represents a minor liquidity event compared with the reported direct beneficial ownership of 2,360,852 shares. The disclosure of the price range and weighted average adds transparency about execution. No derivative transactions or other compensatory equity events are reported on this Form 4. This is a routine disclosure with limited market impact based on the amounts shown.

Matthew Rabinowitz, Presidente Esecutivo e Direttore di Natera, Inc. (NTRA), ha riportato vendite di azioni ordinarie nell'ambito di un piano di negoziazione prestabilito. Il 12/09/2025 la dichiarazione mostra un totale di 5.000 azioni vendute (4.500 e 500 azioni) a prezzi riportati come media ponderata di $170,3083 per un blocco e $172,64 per l'altro, con il blocco maggiore venduto a prezzi compresi tra $170,00 e $170,93. Il modulo afferma che le vendite sono state eseguite ai sensi di un piano di negoziazione Rule 10b5-1 adottato dalla persona che riporta il dato il 13 giugno 2025.

La dichiarazione elenca 2.360.852 azioni detenute direttamente dopo le operazioni riportate. Riporta anche partecipazioni indirecte attribuite a un coniuge di 25.500 e 25.000 azioni su righe separate. Il Form 4 è stato firmato da un procuratore il 16/09/2025.

Matthew Rabinowitz, Presidente Ejecutivo y Director de Natera, Inc. (NTRA), informó ventas de acciones comunes bajo un plan de negociación predeterminado. El 12/09/2025 la presentación muestra un total de 5.000 acciones vendidas (4.500 y 500) a precios reportados como promedio ponderado de $170.3083 para un bloque y $172.64 para el otro, siendo el bloque mayor vendido a precios que oscilan entre $170.00 y $170.93. El Formulario indica que las ventas se realizaron conforme a un plan de negociación 10b5-1 adoptado por la persona que reporta el dato el 13 de junio de 2025.

La declaración lista 2.360.852 acciones poseídas de forma beneficiosa directamente después de las transacciones reportadas. También registra participaciones indirectas atribuidas a un cónyuge de 25.500 y 25.000 acciones en líneas separadas. El Formulario 4 fue firmado por un apoderado el 16/09/2025.

Matthew Rabinowitz, Natera, Inc.의 실행 위원회 의장 겸 이사로서 사전에 확립된 거래 계획에 따라 보통주 매도를 보고했습니다. 2025년 9월 12일 공시에는 총 5,000주 매도가 표시되며(4,500주 및 500주), 한 블록은 $170.3083, 다른 블록은 $172.64의 가중평균가로 보고되었고, 더 큰 블록은 $170.00에서 $170.93 사이의 가격으로 매도되었습니다. 양식은 매매가 보고 의무자이 입수한 2025년 6월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 진행되었음을 명시합니다.

공시는 거래 보고 직후 직접 보유한 2,360,852주의 주식을 나열합니다. 또한 배우자에게 귀속된 간접 보유로 25,500주25,000주가 별도 행에 기록됩니다. Form 4는 2025년 9월 16일에 대리인이 서명했습니다.

Matthew Rabinowitz, Président Exécutif et Directeur de Natera, Inc. (NTRA), a renseigné des ventes d'actions ordinaires dans le cadre d'un plan de négociation préétabli. Le 12/09/2025, le dépôt montre un total de 5 000 actions vendues (4 500 et 500 actions) à des prix rapportés comme moyenne pondérée de 170,3083 USD pour un bloc et 172,64 USD pour l'autre, le bloc le plus important ayant été vendu à des prix allant de 170,00 à 170,93 USD. Le formulaire indique que les ventes ont été effectuées conformément à un plan de négociation Rule 10b5-1 adopté par la personne qui déclare le fait le 13 juin 2025.

Le dépôt répertorie 2 360 852 actions détenues directement après les transactions déclarées. Il indique aussi des participations indirectes attribuées à un conjoint de 25 500 et 25 000 actions sur des lignes séparées. Le formulaire 4 a été signé par un mandataire le 16/09/2025.

Matthew Rabinowitz, Vorstandsvorsitzender und Direktor von Natera, Inc. (NTRA), meldete Verkäufe von Stammaktien im Rahmen eines vorab festgelegten Handelplans. Am 12.09.2025 zeigt die Einreichung insgesamt 5.000 Aktien verkauft (4.500 und 500 Aktien) zu als gewichteter Durchschnitt berichteten Preisen von $170,3083 für einen Block und $172,64 für den anderen, wobei der größere Block zu Preisen von $170,00 bis $170,93 verkauft wurde. Das Formular besagt, dass die Verkäufe gemäß einem am 13. Juni 2025 von der berichtenden Person angenommenen Rule 10b5-1-Handelsplan durchgeführt wurden.

Die Einreichung listet 2.360.852 Aktien unmittelbar nach den berichteten Transaktionen direkt gehalten. Es vermerkt außerdem indirekte Beteiligungen, die einem Ehepartner von 25.500 und 25.000 Aktien zugeordnet sind, auf separaten Zeilen. Das Formular 4 wurde von einem Rechtsvertreter am 16.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Rabinowitz Matthew

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
EXECUTIVE CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 2,360,852 D
Common Stock 09/12/2025 S 4,500(1) D $170.3083(2) 25,500 I By spouse
Common Stock 09/12/2025 S 500(1) D $172.64 25,000 I By spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.93 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Vincent Fontanilla, Attorney-in-Fact 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did NTRA Executive Chairman Matthew Rabinowitz report?

He reported sales totaling 5,000 shares on 09/12/2025 (4,500 and 500 shares) as shown on the Form 4.

Were the NTRA sales part of a 10b5-1 trading plan?

Yes. The Form states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2025.

What prices were reported for the NTRA insider sales?

The larger block was sold at a weighted average price of $170.3083 (individual trades ranged $170.00–$170.93); the smaller block was at $172.64.

How many NTRA shares does the reporting person still beneficially own?

The Form reports 2,360,852 shares beneficially owned directly following the reported transactions.

When was the Form 4 for these NTRA transactions signed?

The signature by attorney-in-fact on the Form 4 is dated 09/16/2025.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

22.46B
132.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN